Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 24% ± 9% | |
GABAergic neuron | 7 studies | 41% ± 23% | |
glutamatergic neuron | 6 studies | 43% ± 24% | |
interneuron | 6 studies | 37% ± 22% | |
microglial cell | 6 studies | 21% ± 4% | |
epithelial cell | 6 studies | 29% ± 8% | |
astrocyte | 6 studies | 29% ± 10% | |
mast cell | 5 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 5 studies | 27% ± 7% | |
hepatocyte | 4 studies | 39% ± 10% | |
macrophage | 4 studies | 24% ± 9% | |
adipocyte | 4 studies | 22% ± 2% | |
GABAergic interneuron | 3 studies | 22% ± 2% | |
dendritic cell | 3 studies | 20% ± 2% | |
pericyte | 3 studies | 20% ± 2% | |
transit amplifying cell | 3 studies | 23% ± 8% | |
smooth muscle cell | 3 studies | 18% ± 3% | |
granule cell | 3 studies | 19% ± 4% | |
cardiac muscle cell | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1612.92 | 2642 / 2642 | 100% | 15.31 | 705 / 705 |
esophagus | 100% | 1265.54 | 1445 / 1445 | 100% | 8.79 | 183 / 183 |
liver | 100% | 2359.23 | 226 / 226 | 100% | 12.63 | 406 / 406 |
ovary | 100% | 1353.15 | 180 / 180 | 100% | 9.23 | 430 / 430 |
prostate | 100% | 1190.47 | 245 / 245 | 100% | 10.59 | 502 / 502 |
lung | 100% | 1233.21 | 577 / 578 | 100% | 9.67 | 1155 / 1155 |
bladder | 100% | 1026.24 | 21 / 21 | 100% | 11.42 | 503 / 504 |
breast | 100% | 924.34 | 459 / 459 | 100% | 9.42 | 1114 / 1118 |
uterus | 100% | 915.04 | 170 / 170 | 100% | 9.50 | 457 / 459 |
kidney | 100% | 2060.22 | 89 / 89 | 100% | 10.85 | 897 / 901 |
thymus | 100% | 1037.75 | 653 / 653 | 100% | 7.95 | 602 / 605 |
stomach | 100% | 972.46 | 359 / 359 | 99% | 10.10 | 284 / 286 |
intestine | 100% | 1184.26 | 966 / 966 | 99% | 10.10 | 523 / 527 |
adrenal gland | 100% | 1658.24 | 258 / 258 | 98% | 10.07 | 226 / 230 |
pancreas | 99% | 662.61 | 325 / 328 | 99% | 8.73 | 176 / 178 |
skin | 99% | 948.66 | 1799 / 1809 | 97% | 9.24 | 458 / 472 |
adipose | 100% | 1100.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1230.95 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1666.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1143.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.37 | 1 / 1 |
heart | 98% | 1167.29 | 844 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 6.04 | 28 / 29 |
peripheral blood | 87% | 873.09 | 811 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 5.63 | 69 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005739 | Cellular component | mitochondrion |
Gene name | TCAIM |
Protein name | T cell activation inhibitor, mitochondrial T-cell activation inhibitor, mitochondrial (Tolerance associated gene-1 protein) (TOAG-1) |
Synonyms | TOAG1 C3orf23 |
Description | FUNCTION: May regulate T-cell apoptosis. . |
Accessions | ENST00000412611.6 [Q8N3R3-2] ENST00000431657.5 [Q8N3R3-2] ENST00000383746.7 [Q8N3R3-3] ENST00000396078.7 [Q8N3R3-3] Q8N3R3 ENST00000417768.1 [Q8N3R3-2] A0A0U1RQT4 ENST00000417237.5 [Q8N3R3-1] ENST00000444602.2 ENST00000342649.9 [Q8N3R3-1] |